Sec23b regulates cell migration by orchestrating collagen I secretion and processing.

This study identifies Sec23b as a novel actin-associated protein that regulates cell migration rates by orchestrating the secretion and post-secretion maturation of Collagen I, utilizing a doxycycline-inducible proximity ligation assay to characterize the actin-associated proteome.

The Gist

The Big Picture: How Cells Move and Why It Matters

Imagine your body is a bustling city. For this city to function, its "workers" (cells) need to move around. They move to heal a cut on your skin, to build new tissue while you grow, or to fight off an infection.

However, sometimes these workers get confused and start moving in the wrong direction or too fast. In cancer, this is a disaster. Cancer cells break away from a tumor, travel through the body (like commuters taking a train), and set up new colonies in distant organs. This is called metastasis, and it's the most dangerous part of cancer.

To move, a cell needs a skeleton made of tiny ropes called actin filaments. Think of actin as the cell's internal scaffolding and muscles. The scientists in this paper wanted to know: What other tools and workers are attached to this scaffolding when a cell decides to move?

The Detective Tool: The "Biotin Drone"

To find out, the researchers built a high-tech detective tool. They created a protein fusion that acts like a drone with a spray paint can.

• The Drone: A small piece of protein called "Lifeact" that loves to stick to the cell's actin ropes.
• The Spray Paint: An enzyme called "miniTurboID" that sprays a tiny tag (biotin) onto any protein that gets close to the drone.

They turned this drone on only when they wanted it to work (using a chemical switch called doxycycline). When the cells started to move (by scratching a line across them to simulate a wound), the drone sprayed tags on all the proteins hanging out near the moving actin ropes. They then caught these tagged proteins and identified them under a microscope.

The Surprise Discovery: The Unlikely Worker

The scientists expected to find standard construction workers like "Moesin" or "Vinculin" (proteins known to help cells grip surfaces). But they found something totally unexpected: a protein called Sec23b.

The Analogy: Imagine you are looking at a construction site where a building is being moved. You expect to see the crane operators and the truck drivers. Instead, you find the delivery truck driver (Sec23b) standing right next to the scaffolding, holding a blueprint.

Sec23b is usually known as a "shipping manager." Its normal job is to pack goods inside the cell (in a warehouse called the Endoplasmic Reticulum) and load them onto trucks to send them out of the cell. It doesn't usually have anything to do with the cell's internal muscles (actin).

The Twist: The researchers discovered that when a cell starts to move, Sec23b actually leaves its usual job at the shipping dock and hops onto the actin "scaffolding." It seems to be coordinating the delivery of materials while the cell is moving.

The Real Job: Delivering the "Glue" (Collagen)

So, what is Sec23b delivering? The answer is Collagen I.

Think of Collagen I as the cement or glue of the body. It forms the roads and sidewalks that cells walk on.

1. The Problem: When the researchers turned off Sec23b (removed the shipping manager), the cells became clumsy. They couldn't spread out, they couldn't grip the ground, and they moved very slowly.
2. The Cause: Without Sec23b, the cell was still making the cement (Collagen), but it was doing a terrible job.
   • It was dumping out the raw, unprocessed cement (called procollagen) in huge piles.
   • But it failed to cut and shape this cement into strong, usable fibers (telocollagen).
3. The Result: The cell was trying to walk on a pile of wet, unformed mud instead of a solid sidewalk. No wonder it couldn't move!

The "Rescue" Experiment

To prove this theory, the scientists did a clever experiment. They took the clumsy cells (with the broken Sec23b) and put them on a surface that was already covered in strong, pre-made collagen fibers (like laying down a pre-paved road).

The Result: Suddenly, the clumsy cells started moving perfectly fine! They didn't need to make their own road anymore; they just needed to walk on the one provided. This proved that Sec23b's only job in this context was to ensure the cell could build its own road (the extracellular matrix) so it could travel.

Why This Matters for Cancer

The researchers looked at data from thousands of breast cancer patients. They found that in many aggressive cancers, the gene for Sec23b is "amplified" (there are too many copies of it).

The Takeaway:

• Too much Sec23b might mean the cancer cells are super-efficient at building their own "roads" (collagen highways).
• This allows them to travel faster and spread to other parts of the body more easily.
• The study suggests that if we can figure out how to stop Sec23b from doing its job, we might be able to stop cancer cells from migrating and spreading.

Summary in One Sentence

This paper discovered that a protein usually responsible for shipping goods inside a cell (Sec23b) actually jumps onto the cell's movement muscles to help deliver and assemble the "cement" (collagen) that cells need to walk on, and when this process goes wrong in cancer, it helps tumors spread.

Technical Summary

1. Problem Statement

Cell migration is a fundamental biological process essential for development and wound healing, but its dysregulation drives pathological conditions such as cancer metastasis. While the actin cytoskeleton is known to be the primary driver of cell motility, the dynamic proteome associated with actin during the initiation of migration remains incompletely characterized. Most existing methods (e.g., immunoprecipitation, yeast two-hybrid) capture protein interactions at steady state, failing to reveal the transient, dynamic changes in the "actin cytoskeletome" that occur when cells transition from a resting to a migrating state. Furthermore, the molecular mechanisms linking intracellular trafficking machinery to extracellular matrix (ECM) remodeling during migration are not fully understood.

2. Methodology

The authors employed a multi-faceted approach combining proximity-dependent biotinylation, proteomics, live-cell imaging, and functional assays:

• Proximity Ligation Assay (BioID):
  • Developed a doxycycline-inducible miniTurboID-Lifeact fusion probe. Lifeact (a 17-amino acid peptide) binds actin, while miniTurboID is a rapid, promiscuous biotin ligase.
  • Validation: Cells were treated with Cytochalasin D (an actin polymerization inhibitor) to shift the actin pool from F-actin to G-actin. This validated the probe's ability to distinguish between F-actin and G-actin associated proteins.
  • Migration Assay: MDA-MB-231 triple-negative breast cancer cells were subjected to a scratch wound to induce migration. The probe was pulsed with biotin for 30 minutes during the early stages of migration (1.5 hours post-scratch) to label proximal proteins.
• Proteomics (Mass Spectrometry):
  • Biotinylated proteins were enriched using streptavidin beads and analyzed via LC-MS/MS.
  • Data analysis included Bayesian False Discovery Rate (BFDR) filtering and Gene Set Enrichment Analysis (GSEA) to identify differentially labeled proteins.
• Live-Cell Imaging:
  • Triple-labeling of GFP-Sec23b (COPII component), mCherry-Lifeact (F-actin), and 670-EB3 (microtubule plus-ends) to track subcellular localization dynamics in real-time.
  • Kymograph analysis was used to quantify the shift in Sec23b localization.
• Functional Validation:
  • Knockdown (KD): Two independent shRNAs were used to deplete Sec23b in MDA-MB-231 cells.
  • Migration/Spreading Assays: Scratch wound closure, random migration velocity tracking (IncuCyte), and cell spreading area measurements.
  • Secretion & Processing Assays:
    • RUSH Assay: Used mApple-GPI-RUSH to track COPII vesicle trafficking speed.
    • Collagen Analysis: Western blotting of conditioned media to detect secreted procollagen I (N-terminal domain) vs. telocollagen I (cleaved, mature form). Immunofluorescence was used to quantify fibrillar collagen deposition.
  • Rescue Experiments: Cells were plated on rat tail collagen I (fibrous) vs. gelatin (denatured collagen) to test if exogenous functional collagen could rescue migration defects.
• Clinical Correlation: Analysis of the METABRIC breast cancer database to correlate Sec23b copy number amplifications with patient survival.

3. Key Contributions

• Novel Proteomic Tool: Validated miniTurboID-Lifeact as a high-resolution tool for capturing dynamic, time-specific changes in the actin-associated proteome during cell migration initiation.
• Discovery of Sec23b: Identified Sec23b (a core component of the COPII coat complex) as an unexpected, highly dynamic actin-associated protein that increases its association with F-actin during migration.
• Mechanistic Link: Established a direct functional link between the intracellular secretory machinery (COPII/Sec23b) and the extracellular matrix organization required for cell migration.
• Collagen Processing Mechanism: Demonstrated that Sec23b is not just a transporter but is critical for the post-secretion maturation of Collagen I, specifically the proteolytic cleavage required to form functional fibrils.

4. Key Results

• Proteomic Profiling:
  • In Cytochalasin D-treated cells, F-actin binding proteins (e.g., Vinculin, Moesin) showed reduced biotinylation, while G-actin binders (e.g., Profilin1) increased.
  • In migrating (scratched) cells, Sec23b was the third most highly biotinylated protein, showing a significant increase in proximity to F-actin compared to resting cells.
• Subcellular Localization:
  • Live imaging revealed that in resting cells, Sec23b puncta co-localize with microtubules (EB3).
  • Upon migration induction, Sec23b particles switch localization from microtubules to F-actin structures (lamellipodia/filopodia).
• Functional Impact of Sec23b Depletion:
  • Migration Defect: Sec23b knockdown significantly reduced cell spreading, delayed scratch wound closure, and decreased random migration velocity.
  • Focal Adhesions: KD cells exhibited smaller, rounder focal adhesions, indicating impaired maturation.
  • Actin Independence: Sec23b KD did not alter total F-actin levels or organization, suggesting its role is indirect (via ECM interaction) rather than direct cytoskeletal regulation.
• Collagen I Dysregulation:
  • Sec23b depletion caused a >20-fold increase in secreted soluble procollagen I (uncleaved) in the media.
  • Conversely, there was a ~25% decrease in telocollagen I (cleaved, fibrillar collagen) deposited in the ECM.
  • COPII Trafficking: Sec23b depletion paradoxically increased the speed of GPI-marked COPII vesicle trafficking, suggesting a loss of regulation rather than a blockage.
• Rescue and Clinical Relevance:
  • The migration defect caused by Sec23b KD was rescued by plating cells on pre-coated rat tail collagen I (functional fibrils) but not on gelatin. This confirms the defect is due to the lack of functional ECM, not an intrinsic inability to move.
  • In breast cancer patients, Sec23b amplification correlates with lower relapse-free survival, linking the protein's role in collagen secretion to metastatic progression.

5. Significance

This study fundamentally shifts the understanding of cell migration by revealing that efficient motility relies not only on cytoskeletal dynamics but also on the precise orchestration of ECM secretion and maturation.

• Novel Mechanism: It identifies a "secretory-cytoskeletal" axis where Sec23b acts as a bridge, associating with F-actin to ensure the correct processing of Collagen I. Without Sec23b, cells secrete excessive uncleaved procollagen that fails to form the structural fibrils necessary for traction.
• Therapeutic Implications: Given the correlation between Sec23b amplification and poor breast cancer prognosis, Sec23b represents a potential therapeutic target. Inhibiting Sec23b could disrupt the tumor microenvironment's collagen architecture, potentially hindering metastasis.
• Methodological Advance: The miniTurboID-Lifeact approach provides a robust framework for future studies to map the dynamic interactome of the cytoskeleton during specific cellular transitions, moving beyond static snapshots of protein interactions.